2019 American Transplant Congress
Long-Term Efficacy of Direct-Acting Antiviral Agents
Beijing Friendship Hospital, Capital Medical University, Beijing, China
*Purpose: Long-term efficacy of direct-acting antiviral agents (DAAs) therapy in kidney transplant recipients was unknown. Thus, we aimed to evaluate it in a Chinese cohort…2019 American Transplant Congress
Kidney Transplant Outcomes in Patients with ESRD Due to Myeloma
Indiana University School of Medicine, Indianapolis, IN
*Purpose: Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy. Outcomes…2019 American Transplant Congress
Novel Insights into Blocking the IL-6 / IL-6 Receptor Pathway after Pig Kidney Xenotransplantation in Baboons
1Surgery, University of Alabama at Birmingham, Birmingham, AL, 2Revivicor Inc., Blacksburg, VA
*Purpose: IL-6 plays an important role in inflammation. The aims of the study were (i) to measure IL-6 in serum in baboons that received IL-6…2019 American Transplant Congress
CMV Risk Status Remains a Relevant Risk Factor for Long-Term Outcomes
*Purpose: Intensification of immunosuppression using T cell depleting induction has reduced rates of acute cellular rejection after kidney transplantation. Belatacept, a first in class T…2019 American Transplant Congress
Bortezomib Based Induction Therapy Decreases Delayed Graft Function in High Risk Kidney Transplantation
*Purpose: Over 100,000 candidates await a kidney transplant on the national United Network for Organ Sharing (UNOS) waitlist. Among these candidates, one-third have pre-formed antibodies…2019 American Transplant Congress
Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study
1TRANSFORM Study Group, Basel, Switzerland, 2Novartis Pharma AG, Basel, Switzerland
*Purpose: To compare the antirejection efficacy outcomes of an everolimus+reduced-exposure CNI (EVR+rCNI) vs mycophenolic acid+standard-exposure CNI (MPA+sCNI) regimen in renal transplant recipients (RTxRs) from the…2019 American Transplant Congress
Preemptive Kidney Transplantation: Is There a Role for ABO Incompatible Transplantation?
1University of Alabama at Birmingham, Birmingham, AL, 2University of Pennsylvania, Philadelphia, PA
*Purpose: Barriers to kidney transplantation (KT) exist, including ABO incompatibility (ABOi) between potential living kidney donors and transplant candidates. Incompatible pairs can undergo desensitization or…2019 American Transplant Congress
A Single-Center Experience with a 6-Month Regimen of Pneumocystis jiroveci Pneumonia Prophylaxis in HIV-Positive Kidney Transplant Recipients
*Purpose: Pneumocystis jiroveci pneumonia (PJP) prophylaxis is recommended for all kidney transplant recipients (KTR) for after transplant. HIV-positive KTRs represent a unique subset, and there…2019 American Transplant Congress
Your Path to Transplant Education Increases Patients’ Transplant Knowledge, Attitudes, Informed Decision-Making, and Pursuit: An Randomized Controlled Trial
*Purpose: Most kidney transplant (KT) education is “one-size-fits-all” where patients’ unique gaps in knowledge, challenges, and level of readiness to pursue KT and living donor…2019 American Transplant Congress
Comparison of Minimal Incision Kidney Transplantation with Conventional Incision Kidney Transplantation: Interim Report of a Randomized Controlled Trial
*Purpose: Minimally invasive surgery is rarely applied in kidney transplantation. Few studies have mentioned small incision kidney transplantation, while the incision length is still about…
- « Previous Page
- 1
- …
- 205
- 206
- 207
- 208
- 209
- …
- 531
- Next Page »